[Retracted] MicroRNA-24-3p inhibition prevents cell growth of vascular smooth muscle cells by targeting Bcl-2-like protein 11
Huanxin Zhang, Shizhen Xue, Yi Feng, Jun Shen, Jixian Zhao
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMicroRNA in disease regulation · Circular RNAs in diseases · Nuclear Receptors and Signaling
Exp Ther Med 19:2467–2474, 2020; DOI: 10.3892/etm.2020.8517
Following the publication of this paper, it was drawn to the Editor’s attention by a concerned reader that flow cytometric (FCM) assay data featured in Fig. 4 were strikingly similar to FCM data which were ultimately published in a number of other papers in different journals that were written by different authors at different research institutes, several of which had already been submitted for publication prior to the receipt of this article at Experimental and Therapeutic Medicine.
Owing to the fact that the contentious data in the above article were found to be strikingly similar to data that have been published elsewhere in other papers in different journals, the Editor of Experimental and Therapeutic Medicine has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.